Product
FF via ELLIPTA DPI
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled CorticosteroidsStatus: Completed, Estimated PCD: 2022-03-21